CASE REPORT
===========

A 40-year-old man with Hepatitis C and a history of cocaine abuse presented with multiple stages of painful rashes on his extremities and ears. On examination, the patient had several areas of purpuric macules and retiform purpura to his legs and ears ([Figures 1](#f1-wjem-14-149){ref-type="fig"} and [2](#f2-wjem-14-149){ref-type="fig"}), as well as large ulcerations with erythematous borders on bilateral lower extremities ([Figure 3](#f3-wjem-14-149){ref-type="fig"}). Laboratory studies revealed mild leukopenia (white blood cell 3.8 K/uL), positive anti-nuclear antibody (ANA), and negative cryoglobulins. Anti-myeloperoxidase antibodies (MPO-ANCA) and anti-proteinase-3 (PR3-ANCA) were also positive. Skin biopsy revealed dermal purpura and thrombi.

DISCUSSION
==========

This patient presented with characteristic findings of levamisole-toxicity. Levamisole is not an inert substance but an antihelmithic drug and potent immunomodulator that was once used for treating cancer and certain autoimmune diseases.[@b1-wjem-14-149]--[@b2-wjem-14-149] Levamisole is also an increasingly popular cocaine-adulterant[@b3-wjem-14-149] linked to a growing number of cutanousvasculitis cases characterized by neutropenia or leukopenia, purpuric rash, and production of certain autoantibodies.[@b4-wjem-14-149] It was these side effects that caused Levamisole to be withdrawn from the market in 2000. It is unknown why Levamisole has become an increasingly popular cocaine adulterant in the U.S. and Canada. It has been hypothesized that the cutting agent may intensify or prolong the stimulant properties of cocaine by its effects on the metabolism of monoamine neurotransmitters, specifically dopamine.[@b5-wjem-14-149],[@b6-wjem-14-149] Levamisole's chemical properties also make detecting it in street purity tests difficult. Resolution of the cutaneous and hematologic effects often occurs spontaneously with discontinuation of the drug.
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